Development and production of pharmaceuticals, with a focus on research and development using artificial intelligence for new drug discovery.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
Medincell
A
Development of innovative pharmaceutical and biotechnology products, focusing on advanced drug delivery systems.
CordenPharma
B
Development and manufacturing of active pharmaceutical ingredients (APIs), drug products, and lipid excipients for the pharmaceutical industry.
Transgene
A
Development of innovative immunotherapies against cancer using advanced genetic engineering and artificial intelligence technologies.
Initiatives identified among leaders
Participer au développement des Objectifs de Développement Durable
“Medincell participe au développement des Objectifs...” - MedincellAlignement avec les objectifs de développement durable
“Transgene s'aligne avec les objectifs de développe...” - TransgeneRéduction des émissions de gaz à effet de serre et investissement dans des technologies durables
“CordenPharma s'engage à réduire ses émissions de g...” - CordenPharma46% of similar organizations communicate on CSR issues
+2510 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports